Regulatory Updates
Aug 23, 2026•1 min read
PMDA Revises Precautions for Donanemab and Other Drugs
The Pharmaceuticals and Medical Devices Agency (PMDA) has posted updated precautionary information for Donanemab and other medicines.
Regulatory Updates
Aug 23, 2026•1 min read
Crescent Pharma Recalls Ramipril 10mg Capsules Batch
Crescent Pharma Limited is recalling a batch of Ramipril 10mg capsules as a precaution due to a possible manufacturing error.
1
Regulatory Updates
Aug 23, 2026•1 min read
Amarox Limited recalls Sertraline 100 mg tablets batch over manufacturing error
Amarox Limited is recalling a batch of 100 mg film‑coated sertraline tablets due to a manufacturing site error.
Regulatory Updates
Aug 23, 2026•1 min read
Crescent Pharma Initiates Precautionary Recall of Ramipril 2.5 mg Capsules
Crescent Pharma Limited is recalling a batch of 2.5 mg Ramipril capsules due to a possible packaging error.
Regulatory Updates
Aug 23, 2026•1 min read
Becton Dickinson UK recalls ChloraPrep 2% applicators over sterility concerns
Becton Dickinson UK Ltd is recalling batches of ChloraPrep 2% 1 mL and ChloraPrep Frepp 2% 1.5 mL applicators due to a potential sterility breach in packaging.
1
Regulatory Updates
Aug 23, 2026•1 min read
MHRA publishes Field Safety Notices for 27‑31 July 2026
The UK Medicines and Healthcare products Regulatory Agency released a list of Field Safety Notices covering 27 to 31 July 2026.
Regulatory Updates
Aug 23, 2026•1 min read
Zentiva UK Pharma recalls Fingolimod 0.5 mg capsules over metal contamination risk
Zentiva UK Pharma Limited is recalling a batch of 0.5 mg Fingolimod capsules due to possible metal particle contamination.
1
Regulatory Updates
Aug 23, 2026•1 min read
FDA Recalls Product Due to Lack of Assurance of Sterility
The FDA has issued a recall for a product because sterility could not be assured.
1
Regulatory Updates
Aug 23, 2026•1 min read
Orbit Pharma Recalls Cyclizine Lactate Injection Batch Over GMP Deficiencies
Orbit Pharma Limited is recalling a batch of Cyclizine Lactate 50 mg/ml injection solution due to GMP deficiencies at the manufacturing site.
1